View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
BV-ICE - Brentuximab Vedotin 1.8 / Etoposide 100 / Carboplatin 5 / Ifosfamide 5, T-cell Lymphoma
Protocol-ID: 2420 V1.0 (Mini), BV-ICE (BRNT1.8/ETOP100/CRBP5/IFOS5), T-NHLIndication(s)
- NHL, T-cell type (CD30+); ICD-10 C84.5
- NHL, T-Cell Type, Adult T-Cell Leukemia or Lymphoma (CD30+); ICD-10 C91.5-
- NHL, T-Cell Type, Anaplastic Large Cell (CD30+); ICD-10 C84.4
- NHL, T-Cell Type, Anaplastic Large Cell Lymphoma, ALK negative (CD30+); ICD-10 C84.7
- NHL, T-Cell Type, Anaplastic Large Cell Lymphoma, ALK-positive (CD30+); ICD-10 C84.6
- NHL, T-Cell Type, Angioimmunoblastic (CD30+); ICD-10 C86.5
- NHL, T-Cell Type, Enteropathy Type (CD30+); ICD-10 C86.2
- NHL, T-Cell Type, Hepatosplenic (CD30+); ICD-10 C86.1
- NHL, T-Cell Type, Peripheral, Unspecified (CD30+); ICD-10 C84.4
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 30.08.2023